Literature DB >> 7808243

Effects of exercise intensity, duration, and time of day on fibrinolytic activity in physically active men.

L M Szymanski1, R R Pate.   

Abstract

The purposes of this investigation were to determine: 1) whether the fibrinolytic responses to acute, submaximal exercise were best related to intensity, duration, or total caloric expenditure; and 2) whether the time of day exercise is performed affects the fibrinolytic response. Twelve physically active men (mean age = 34.8 +/- 4.0 yr) performed four 30-min exercise sessions: 50% VO2max, a.m. and p.m., and 80% VO2max, a.m. and p.m. Blood samples were analyzed for tissue plasminogen activator (TPA) activity and plasminogen activator inhibitor-1 (PAI-1) activity. Data were analyzed using a three-way ANOVA with repeated measures. TPA activity: preexercise TPA did not differ among the four sessions. TPA increased with exercise in all sessions except the 50% a.m. session. Exercise at 80% increased TPA more than 50% (P < 0.001) and evening sessions increased TPA more than morning sessions (P < 0.05). PAI-1 activity: preexercise PAI-1 activity was higher during the morning than evening and significantly decreased with exercise in all sessions except the 50% p.m. session. It was concluded that changes in fibrinolytic activity appear to be influenced primarily by exercise intensity rather than duration or total caloric expenditure. Additionally, time of day of exercise performance significantly influenced fibrinolytic activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7808243

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  12 in total

Review 1.  Effects of strenuous exercise on haemostasis.

Authors:  J E Smith
Journal:  Br J Sports Med       Date:  2003       Impact factor: 13.800

Review 2.  Chronobiological considerations for exercise and heart disease.

Authors:  Greg Atkinson; Barry Drust; Keith George; Thomas Reilly; Jim Waterhouse
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

Review 3.  Effects of exercise on blood coagulation, fibrinolysis and platelet aggregation.

Authors:  M S el-Sayed
Journal:  Sports Med       Date:  1996-11       Impact factor: 11.136

Review 4.  Effects of exercise training on abdominal obesity and related metabolic complications.

Authors:  B Buemann; A Tremblay
Journal:  Sports Med       Date:  1996-03       Impact factor: 11.136

5.  Blood coagulation and fibrinolysis in healthy, untrained subjects: effects of different exercise intensities controlled by individual anaerobic threshold.

Authors:  Kathleen Menzel; Thomas Hilberg
Journal:  Eur J Appl Physiol       Date:  2010-09-22       Impact factor: 3.078

6.  The effect of time of day and exercise on platelet functions and platelet-neutrophil aggregates in healthy male subjects.

Authors:  Hatice Aldemir; Nedret Kiliç
Journal:  Mol Cell Biochem       Date:  2005-12       Impact factor: 3.396

7.  Circadian variation in the circulatory responses to exercise: relevance to the morning peaks in strokes and cardiac events.

Authors:  Greg Atkinson; Helen Jones; Philip N Ainslie
Journal:  Eur J Appl Physiol       Date:  2009-10-14       Impact factor: 3.078

8.  Increased thrombotic and impaired fibrinolytic response to acute exercise in patients with essential hypertension: the effect of treatment with an angiotensin II receptor blocker.

Authors:  E Gavriilaki; E Gkaliagkousi; B Nikolaidou; G Triantafyllou; F Chatzopoulou; S Douma
Journal:  J Hum Hypertens       Date:  2014-03-13       Impact factor: 3.012

Review 9.  Exercise-induced changes in coagulation and fibrinolysis in healthy populations and patients with cardiovascular disease.

Authors:  Christopher J Womack; Paul R Nagelkirk; Adam M Coughlin
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

Review 10.  Exercise and training effects on blood haemostasis in health and disease: an update.

Authors:  Mahmoud S El-Sayed; Zeinab El-Sayed Ali; Sajad Ahmadizad
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.